Boutros SOUTOU
Faculté de médecine – Professeur associé
Faculté de pharmacie – Professeur associé
+961 (1) 421 000 boutros.soutou@usj.edu.lb
p class=MsoNormal style=margin: 0cm line-height: normal; font-family: Times New Roman, serif;>Dermatologue libanais, 15 ans d’expérience.Arabe, français et anglais lus, écrits et parlés.45 ansMembre de lOrdre des médecins du Nord; 1741.membre de la société libanaise de dermatologie; membre de la société française de dermatologie et du groupe thématique Urticaire.
Education
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| master en sciences biologiques et médicales | Saint Joseph University of Beyrouth | Liban | 2022 |
| diplome universitaire d'éducation en sciences de la santé | Saint Joseph University of Beyrouth | Liban | 2016 |
| diplome interuniversitaire de dermatologie esthetique, lasers et cosmetologie | Université Paris 7- Denis Diderot | France | 2009 |
| Diplome de spécialisation - Dermatologie | Saint Joseph University of Beyrouth | Liban | 2008 |
| attestation de formation spécialisée | Université Pierre et Marie Curie (Paris VI) | France | 2008 |
| Diplome de docteur en médecine | Saint Joseph University of Beyrouth | Liban | 2003 |
| C1 de génétique | Saint Joseph University of Beyrouth | Liban | 1998 |
Enseignement à l'USJ
Enseignement universitaire hors USJ
Expérience professionnelle hors USJ
Domaine d’expertise
Thématiques de recherche
p class=MsoNormal" style="margin: 0cm 0cm 10pt line-height: 18.4px;"><b><span lang="FR" style="line-height: 16.866667px;"><font face="Perpetua, serif"><span style="font-size: 11pt;">Recherche clinique continue avec de multiples publications (cf. publications) : Département de dermatologie, Faculté de Médecine, USJ ; service de dermatologie, Hôtel-Dieu de France. [lasers, urticaire, </span><span style="font-size: 14.666667px;">acné</span><span style="font-size: 11pt;">, grossesse...]</span></font></span></b></p><p class="MsoNormal" style="margin: 0cm 0cm 10pt; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Recherche fondamentale (en cours): Projet multidisciplinaire « Microbiome cutané et grossesse FPH87 » Tuteur : Pr Dolla Karam Sarkis Laboratoire des agents pathogènes - Faculté de Pharmacie et laboratoire de physiologie - Faculté de Médecine, USJ.<o:p></o:p></span></b></p>
Publications et communications
p class=Default" style="margin: 0cm font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">SAID FE, SHAMI P, RAZZOUK B, <b>SOUTOU B</b>, BRIHI E, SALAMOUN W, AFTIMOS G, SAADE M. Secondary Axillary Node Carcinoma Following Treatment of Hodgkin’s Disease. </span><b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">Breast J 2004</span></b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">; 10: 167-168.<o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">, JAMOUS R, HELOU J. Lettre à la rédaction. Risques oculaires présumés du laser chez les dermatologues (Presumed exposure of dermatologists to ocular risks of laser). <b>Ann Dermatol Venereol 2008</b>; 135: 508-9. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">TOMB R, <b>SOUTOU B</b>. Cas pour diagnostic : Éruption estivale récidivante. Recurrent summer rash. <b>Ann Dermatol Venereol 2008</b>; 135: 873-4. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">TOMB R, <b>SOUTOU B</b>. Deux cas de kératose lichénoïde chronique dans une même fratrie. </span><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">Réponse favorable à la photothérapie UVB. Keratosis lichenoides chronica in two siblings with marked response to UVB phototherapy. </span><b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">Ann Dermatol Venereol 2008</span></b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">; 135: 835-8. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">TOMB R, <b>SOUTOU B</b>, ZALLOUA P. Dysplasie ectodermique anhidrotique familiale : une mutation rare du gène EDA1. </span><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">Anhidrotic ectodermal dysplasia. Report of a rare mutation in EDA1. </span><b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">Ann Dermatol Venereol 2009</span></b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">; 136: 28-31. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">TOMB R, <b>SOUTOU B</b>. Cas pour diagnostic : Ulcérations douloureuses périorificielles chroniques. Persistent painful periorificial ulcerations. <b>Ann Dermatol Venereol 2009</b>; 136: 62-64.<o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">TOMB R, <b>SOUTOU B</b>, CHEHADI S. Hypodermite à plasmocytes, variante histologique de la morphée profonde. </span><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">Plasma cell panniculitis: A histopathological variant of morphea profunda. <b>Ann Dermatol Venereol 2009</b>; 136: 256-9.<o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">, ARACTINGI S. Myeloproliferative disorder therapy: assessment management of adverse events-a dermatologists perspective. </span><b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">Hematol Oncol 2009</span></b><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">; 27(S1):11-13. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="FR" style="font-size: 11pt; font-family: Perpetua, serif;">HELOU J, <b>SOUTOU B</b>, JAMOUS R, TOMB R. Nouveaux effets indésirables du laser dépilatoire axillaire. </span><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">Novel adverse effects of laser-assisted axillary hair removal. <b>Ann dermatol Venereol 2009</b>; 136: 495-500. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">, NASSAR D, RÉGNIER S, PARANT O, KHOSROTEHRANI K, ARACTINGI S. Dermatological manifestations associated with pregnancy. <b>Exp Rev Dermatol 2009</b>; 4: 329-340. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">NASSAR D, <b>SOUTOU B</b>, ARACTINGI S. Cutaneous side effects of EGF receptor inhibitors. <b>Bull Cancer 2009</b>; 96: S85-91. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">, VIGNON-PENNAMEN D, CHOSIDOW O. Neutrophilic dermatoses. <b>Rev Med Interne 2011</b>; 32: 306-13. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;">FRANCÈS C, COSNES A, DUHAUT P, ZAHR N, <b>SOUTOU B</b>, INGEN-HOUSZ-ORO S, BESSIS D, CHEVRANT-BRETON J, CORDEL N, LIPSKER D, COSTEDOAT-CHALUMEAU N. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. <b>Arch Dermatol 2012</b>;148:479-84. <o:p></o:p></span></p><p class="Default" style="margin: 0cm; font-family: Calibri, sans-serif;"><span lang="EN-US" style="font-size: 11pt; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">BARREAU M, DOMPMARTIN-BLANCHÈRE A, JAMOUS R, CHABABI M, <b>SOUTOU B</b>, REYNIER-REZZI J, LAPLAUD AL, ACHER A, ROD J, JEANNE-PASQUIER C, FRAITAG S. Nodular Lesions of Self-healing Juvenile Cutaneous Mucinosis: A Pitfall! <b>Am J Dermatopathol 2012; </b>34:699-705.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">ABU-RUSTUM RS, FRANGIEH A, FAHED R, <b>SOUTOU</b> <b>B</b>, ABDELAHAD A. Limitations of 3-dimensional sonography in the prenatal evaluation of a skin denudation syndrome. <b>J Ultrasound Med 2013</b>; 32: 1301-3.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"><o:p> </o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">Biazar C, Sigges J, Patsinakidis N, Ruland V, Amler S, Bonsmann G, Kuhn A; EUSCLE co-authors [Haust M, Nyberg F, Bata Z, Mihályi L, Olteanu R, Pujol RM, Sánchez-Schmidt JM, Medenica L, Skiljevic D, Reich A, Szepietowski JC, Dalle Vedove C, Girolomoni G, Hawro T, Zalewska-Janowska A, Glaeser R, Huegel R, Jedli</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; background: white;">č</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">kov</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">á</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"> H, Bygum A, Laurinaviciene R, Benoit S, Broecker E, Bahmer FA, Aberer E, Wutte N, Lipozencic J, Marinovic B, S</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">á</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">rdy M, Bekou V, Ruzicka T, Frances C, <b>Soutou B</b>, Lee H, Worm M, Gruschke A, Hunzelmann N, Steinbrink K, Romiti R, Sticherling M, Efurt-Berge C, Averinou G, Papafragkaki D, Antiga E, Caproni M, Mayer B, Volc-Platzer B, Kreuter A, Tiggs C, Heil PM, Stingl G]</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).</span><span lang="EN-US" style="font-family: Perpetua, serif;"></span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">Autoimmun Rev 2013</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">;12:444-54.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"><o:p> </o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">Sigges J, Biazar C, Landmann A, Ruland V, Patsinakidis N, Amler S, Bonsmann G, Kuhn A; EUSCLE Co-Authors [Haust M, Nyberg F, Beta Z, Mihályi L, Olteanu R, Pujol RM, Sánchez-Schmidt JM, Medenica L, Skiljevic D, Reich A, Szepietowski JC, Dalle Vedove C, Girolomoni G, Hawro T, Zalewska-Janowska A, Glaeser R, Huegel R, Jedli</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; background: white;">č</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">kov</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">á</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"> H, Bygum A, Laurinaviciene R, Benoit S, Broecker E, Bahmer FA, Aberer E, Wutte N, Lipozencic J, Marinovic B, Sárdy M, Bekou V, Ruzicka T, Frances C, <b>Soutou B</b>, Lee H, Worm M, Gruschke A, Hunzelmann N, Steinbrink K, Romiti R, Sticherling M, Erfurt-Berge C, Avgerinou G, Papafragkaki D, Antiga E, Caproni M, Mayer B, Volc-Platzer B, Kreuter A, Tigges C, Heil PM, Stingl G] Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;">Autoimmun Rev</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"> <b>2013</b>;12:694-702.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif; background: white;"><o:p> </o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">HELOU J, HABRE M, <b>SOUTOU B</b>, MAATOUK I, IBRAHIM T, TOMB R. Reversibility of hyperhidrosis post axillary depilatory laser.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Lasers Med Sci 2014</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">; 29: 717-21.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G; EUSCLE coauthors [Haust M, Nyberg F, Bata Z, Mihályi L, Olteanu R, Pujol RM, Sánchez-Schmidt JM, Medenica L, Skiljevic D, Reich A, Szepietowski JC, Dalle Vedove C, Girolomoni G, Hawro T, Zalewska-Janowska A, Glaeser R, Huegel R, Jedli</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px;">č</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">kov</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">á</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> H, Bygum A, Laurinaviciene R, Benoit S, Broecker E, Bahmer FA, Aberer E, Wutte N, Lipozencic J, Marinovic B, S</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">á</span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">rdy M, Bekou V, Ruzicka T, Frances C,<b>Soutou B</b>, Lee H, Worm M, Gruschke A, Hunzelmann N, Steinbrink K, Romiti R, Sticherling M, Erfurt-Berge C, Avgerinou G, Papafragkaki D, Antiga E, Caproni M, Mayer B, Volc-Platzer B, Kreuter A, Tigges C, Heil PM, Stingl G]. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Br J Dermatol 2014</span></b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">;171:571-9.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU </span></b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">B, ARACTINGI S. Dermatoses spécifiques de la grossesse. </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Rev Med Interne 2015</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">; 36: 198-202.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU </span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">B, ARACTINGI S. Skin disease in pregnancy. </span><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Best Pract Res Clin Obstet Gynaecol</span></b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> <b>2015</b>; 29: 732-40.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B, </span></b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">ARACTINGI S. Peau et grossesse. Mise au Point.</span><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> La Revue du Praticien 2017 ; </span></b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">67 : 411-414.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">BADDOURA R, GHANEM A, HALABY E, <b>SOUTOU B</b>, TOMB R.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Screening for psoriatic arthritis: targeting phenotypes may improve case detection. </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Joint Bone Spine</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">2019</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> May 5 [Epub ahead of print].<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">ZOGHAIB S, KECHICHIAN E, SOUAID K, </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, HELOU J, TOMB R.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Triggers, clinical manifestations, and management of pediatric erythema multiforme: A systematic review.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">J Am Acad Dermatol 2019</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">; 81:813-822.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Amsler E, Du Thanh A, Soria A, Berard F, Viguier M, Lefevre S, Vigan M, Barzegar C, Boussaid R, Hacard F, Gabison G, Staumont D, Marmion N, Pouplard C, Delaunay J, Badaoui A, Nosbaum A, Pralong P, Castelain F, Bouillet L, Sarre ME, Vermeulen C, Tetart F, Bachtarzi Z, Doutre MS, Martinache C, Bara C, Augey F, Boccon Gibod I, Nicolas JF, Maatouk I, Mathelier Fusade P, </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Soutou B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, Goujon Henry C, Hoarau C, Crépy MN, Bernier C, Cambazard F, Guinepain MT.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Management of urticaria by French specialists compared to international guideline recommendations.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">J Allergy Clin Immunol Pract</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"></span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">2020;</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">8:1761-1763.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, SENET P, LIONNET F, HABIBI A, ARACTINGI S.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Sickle cell disease induces resistance to cutaneous carcinogenesis.</span><span lang="EN-US" style="font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Orphanet J Rare Dis 2020</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">;15:66. doi: 10.1186/s13023-020-1341-9.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, TOMB R. The Multifaceted Engagement of the Dermatologist in the Covid-19 Pandemic.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SN Comprehensive Clinical Medicine</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">2020</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, 2(9), 1388-1392.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">HELOU J, KORKOMAZ J, STEPHAN F, </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">. Searching predictive factors of efficacy and safety in a fractional CO2 laser. </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Dermatol Ther. 2020 </span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Nov;33(6):e13985.<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">HELOU J, MAATOUK I, </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">.</span><span lang="EN-US"> </span><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Big toenail onychomycosis features associated with response to 1064 nm Nd: YAG laser treatment.</span><span lang="EN-US"> </span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">J Cosmet Dermatol. 2022 </span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Mar;21(3):1031-1035.</span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"><o:p></o:p></span></b></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm 0cm 10pt; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B*</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, MASSIH C*, SLEILATY G,<sup> </sup>TRAK-SMAYRA V,<sup> </sup>NASR M, HELOU J, HOKAYEM N, FERRAN F, SLEILATI FH, STÉPHAN F, HALABI-TAWIL M, TOMB R.</span><b><span lang="EN-US" style="font-size: 10pt; line-height: 15.333332px;"> </span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">Clinical and pathological features associated with high-risk, multiple, and recurrent basal cell carcinomas: a retrospective cohort analysis from the Levantine coast of the Mediterranean Sea. <b>Arch Dermatol Res. 2022 </b>Jan 21. doi: 10.1007/s00403-021-02316-w. * equal contribution<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm 0cm 10pt; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B*</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">, El HACHEM G*, HELOU J, STEPHAN F, KECHICHIAN E, ZEINATY P, TOMB R. Psoriasis features associated with infertility and adverse pregnancy outcomes. <b>Ann Dermatol Venereol. 2022 </b>Feb 17:S0151-9638(22)00005-9. * equal contribution<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm 0cm 10pt; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">HELOU J*, <b>SOUTOU B*</b>. Eight-year sustained efficacy and safety of fractional CO2 laser combined with sun exposure in resistant nonsegmental vitiligo: case report. <b>J Cosmet Dermatol</b>. <b>2022</b> Aug 18. doi: 10.1111/jocd.15315. Epub ahead of print. * equal contribution<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">HELOU J*, <b>SOUTOU B*</b>, MAATOUK I*, MERHY R, ASSAF J, SARKIS AS, JABBOUR R, KAIKATI J, TOMB R. Beneficial UVB phototherapy preceding a fractional CO2 laser-UVB protocol in refractory non-segmental vitiligo.<b> J Cosmet Dermatol.</b></span><span lang="EN-US"></span><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">2022</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> Dec;21(12):6783-6787. doi: 10.1111/jocd.15396. Epub 2022 Sep 25. PMID: 36121343. * equal contribution<o:p></o:p></span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"> </span></p><p class="MsoNormal" style="margin: 0cm; line-height: 18.4px; font-family: "Times New Roman", serif;"><b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">SOUTOU B</span></b><span lang="EN-US" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">*, SLEIMAN J*, TOMB R, KECHICHIAN E, HELOU J. Prevalence of adverse events varies with the different oral isotretinoin brands in acne treatment: a retrospective observational study. <b>Arch Dermatol Res.</b> <b>2023 </b>Jan 19. doi: 10.1007/s00403-023-02532-6. Epub ahead of print. </span><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;">PMID: 36656385. * equal contribution</span><b><span lang="FR" style="font-size: 11pt; line-height: 16.866667px; font-family: Perpetua, serif;"><o:p></o:p></span></b></p>MALLAT F, CHAAYA C, AOUN M, SOUTOU B *, HELOU J*. Adverse events of light-assisted hair removal: an updated review. J Cutan Med Surg. 2023 Jun 5:12034754231174852. doi: 10.1177/12034754231174852. * equal contributionMALLAT F, MATAR S, SOUTOU B. Umbilical seborrheic keratosis developing after diode laser hair removal in an 18-year-old patient. Cosmet Laser Ther. 2023 May 19;25(1-4):54-56.SOUTOU B*, KAIKATI J*, AFIOUNI R, JABBOUR R, SKAFF S, ABOU KHATER J, HELOU J. Refractory single-nail psoriasis cleared with one session of fractional CO2 laser-assisted delivery of methotrexate. Ann Dermatol Venereol. 2024 Jun;151(2):103255. doi: 10.1016/j.annder.2024.103255.SOUTOU B*, RAHME S*, BIZDIKIAN AR, SKAFF S, HELOU J, TOMB R. Iron supplementation may improve not-low-ferritin telogen effluvium: an observational real-life study. Indian J Dermatol. 2024 Mar-Apr;69(2):119-122. doi: 10.4103/ijd.ijd_744_22.SOUTOU B*, EL JALKH J*, IBRAHIM E‡, ABOU JNEID R‡, HELOU J§, TOMB R§. Pediatric epidemiology of skin disorders in a Mediterranean population with a non-referral-based healthcare system: a retrospective large-series analysis. Indian Journal of Paediatric Dermatology 24(4):p 285-290, Oct–Dec 2023. DOI: 10.4103/ijpd.ijpd_30_23FARHAT M, SOUTOU B. Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab. Int J Rheum Dis. 2024 Mar;27(3):e15125.
Anglais
Arabic